REMKX
Price
$18.57
Change
+$0.19 (+1.03%)
Updated
Apr 24 closing price
Net Assets
287.84M
VEMAX
Price
$37.37
Change
+$0.34 (+0.92%)
Updated
Apr 24 closing price
Net Assets
111.75B
Ad is loading...

REMKX vs VEMAX

Header iconREMKX vs VEMAX Comparison
Open Charts REMKX vs VEMAXBanner chart's image
Victory Sophus Emerging Markets R
Price$18.57
Change+$0.19 (+1.03%)
VolumeN/A
Net Assets287.84M
Vanguard Emerging Mkts Stock Idx Adm
Price$37.37
Change+$0.34 (+0.92%)
VolumeN/A
Net Assets111.75B
REMKX vs VEMAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
REMKX vs. VEMAX commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is REMKX is a Buy and VEMAX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VEMAX has more cash in the bank: 112B vs. REMKX (288M). VEMAX pays higher dividends than REMKX: VEMAX (3.08) vs REMKX (1.88). REMKX was incepted earlier than VEMAX: REMKX (24 years) vs VEMAX (19 years). REMKX (1.99) is less costly to investors than VEMAX (0.13). REMKX is a more actively managed with annual turnover of: 72.00 vs. VEMAX (8.00). REMKX has a lower initial minimum investment than VEMAX: REMKX (0) vs VEMAX (3000). VEMAX annual gain was more profitable for investors over the last year : 8.87 vs. REMKX (3.92). VEMAX return over 5 years is better than : 39.58 vs. REMKX (28.41).
REMKXVEMAXREMKX / VEMAX
Total Expense Ratio1.580.131,215%
Annual Report Gross Expense Ratio1.990.131,531%
Fund Existence24 years19 years-
Gain YTD3.5490.767463%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets288M112B0%
Annual Yield % from dividends1.883.0861%
Returns for 1 year3.928.8744%
Returns for 3 years7.1411.1664%
Returns for 5 years28.4139.5872%
Returns for 10 years12.1818.4766%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PHPSX17.38N/A
N/A
ProFunds Pharmaceuticals UltraSector Svc
GSRCX10.70N/A
N/A
Goldman Sachs Rising Dividend Gr C
ESPNX35.35N/A
N/A
Allspring Special Small Cap Value Inst
PZIMX10.69N/A
N/A
Pzena Mid Cap Value Instl
PSPIX21.91N/A
N/A
Principal SmallCap S&P 600 Index R6